Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L-5-methyltetrahydrofolate, also known as levomefolic acid, is the **predominant active form of folate used directly by cells**. It is vital for methyl group donation in the conversion of homocysteine to methionine, supporting DNA synthesis, repair, and neurotransmitter production. It is especially critical during periods of rapid cell division, such as embryonic development, and is the main circulating form of folate capable of crossing the blood-brain barrier[1][2][6][10]. Supplementation is beneficial for individuals with genetic variants affecting folate metabolism, most notably the MTHFR gene[8][6]. L-5-methyltetrahydrofolate is not itself a classical drug target, but is a metabolite and coenzyme necessary for multiple cellular reactions, and its deficiency or altered handling is associated with diseases ranging from cardiovascular to neurodevelopmental disorders[2][4][8][10].
Provides methyl groups for methylation reactions; Promotes homocysteine conversion to methionine
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Levomefolic acid (L-5-methyltetrahydrofolate) (L-5-MTHF).